Holen Sie sich die Stockscreener-App
4.11
34.31%
1.05
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.68%
9.633
|
8.864 | 9.234 | 9.485 | 9.617 |
| Cost Of Revenue |
5.49%
2.584
|
2.734 | 2.43 | 2.819 | 2.803 |
| Gross Profit |
14.99%
7.049
|
6.13 | 6.804 | 6.666 | 6.814 |
Operating Expenses
|
5.59%
9.687
|
9.174 | 11.19 | 9.528 | 10.43 |
| Operating Income/Loss |
13.34%
-2.638
|
-3.044 | -4.385 | -2.862 | -3.615 |
| Nonoperating Income/Loss |
14.68%
-1.779
|
-2.085 | -1.112 | -0.709 | 5.562 |
| Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
| Income Tax Expense/Benefit |
-
|
- | - | -0.401 | - |
|
Net Income/Loss
|
13.88%
-4.417
|
-5.129 | -5.497 | -3.17 | 1.947 |
| Basic Average Shares |
0.11%
62.81
|
62.74 | - | 62.75 | 62.61 |
| Diluted Average Shares |
0.11%
62.81
|
62.74 | - | 62.75 | 67.17 |
| Basic Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.05 | 0.03 |
| Diluted Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.05 | 0.03 |
1.69%
3.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):